Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by lifeishoton Feb 17, 2017 8:03pm

108 Views

Post# 25864179

RE:RE:RE:I'm doing my dd on this

Oilersgoforcup Hey,, I have positions in both stocks and as an honest investor,, I would like to know if there is any connection bt NF and MYM . When I look at both teams, I just can't seem to see a connection, although MYM look good behind the scene and NF look good out in the field, where the real money is grown. Money does grow on trees in this lucrative industry .,,just curious my friend .

Bullboard Posts

Visionstate set to leverage success in the U.S. market